Showing 8 posts of 8 posts found.


Eli Lilly asks for a $24 million tax break for diabetes care facility expansion in Indianapolis

July 24, 2020
Medical Communications Eli Lilly, Humalog, diabetes, insulin

Insulin manufacturer Eli Lilly has requested a $24 million tax break over the next 10 years as an investment into …


FDA approves first short-acting, follow-on biologic of Lilly’s Humalog insulin product

December 12, 2017
Manufacturing and Production, Sales and Marketing Admelog, FDA, Humalog, Sanofi, diabetes, insulin, pharma

The FDA has announced its approval of Sanofi’s Admelog (insulin lispro), the first follow-on biologic version of Eli Lilly’s Humalog …


EMA’s CHMP recommends Sanofi’s Humalog biosimilar

May 22, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, Humalog, Sanofi

Sanofi has received a positive recommendation by the CHMP for its biosimilar to Eli Lilly’s Humalog. The recommendation for approval …


Lily increases diabetes drug by 700% over 20 years

November 3, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernie Sanders, Eli Lily, Humalog, diabetes

It has come to light that, over a 20 year period, Eli Lily has increased the price of its diabetes …

Lantus image

Insulin blockbusters targeted by biosimilar blitz

February 15, 2013
Research and Development, Sales and Marketing Biocon, Humalog, Mylan, insulin

Mylan and Biocon are the latest companies to announce major new plans to develop and market biosimilars. The firms are …

Diabetes prescriptions jump by 50% in England

August 15, 2012
Sales and Marketing Humalog, Januvia, NHS, diabetes, spending

Diabetes prescriptions in England have for the first time topped 40 million this year, a rise of nearly 50% compared …

Pfizer picture

Pfizer pulls out of $350 million insulin pact

March 14, 2012
Research and Development, Sales and Marketing Biocon, Humalog, Lantus, NovoLog, Pfizer

Pfizer has walked away from a research deal with India’s biggest biotech firm Biocon. Both companies were working on a …

Failings at Lilly Humalog plant catch FDA’s eye

February 26, 2010
Manufacturing and Production Humalog, lilly

Eli Lilly has been sent a warning letter about a production facility in Puerto Rico, which says the company failed …

Latest content